skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 16,526  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: subject: Clinical Trials remove subject: Patients remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms
Material Type:
Article
Add to My Research

Traditional Chinese Medicine for Cardiovascular Disease: Evidence and Potential Mechanisms

Journal of the American College of Cardiology, 2017-06, Vol.69 (24), p.2952-2966 [Peer Reviewed Journal]

Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Jun 20, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.04.041 ;PMID: 28619197

Full text available

2
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
Material Type:
Article
Add to My Research

Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease

The New England journal of medicine, 2019-10, Vol.381 (16), p.1557-1567 [Peer Reviewed Journal]

Copyright © 2019 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra1806939

Full text available

3
Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of Bempedoic Acid vs Placebo Added to Maximally Tolerated Statins on Low-Density Lipoprotein Cholesterol in Patients at High Risk for Cardiovascular Disease: The CLEAR Wisdom Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2019-11, Vol.322 (18), p.1780 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2019.16585 ;PMID: 31714986

Digital Resources/Online E-Resources

4
Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial
Material Type:
Article
Add to My Research

Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial

The Lancet (British edition), 2022-05, Vol.399 (10338), p.1876-1885 [Peer Reviewed Journal]

2022 Elsevier Ltd ;Copyright © 2022 Elsevier Ltd. All rights reserved. ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)00122-2 ;PMID: 35525255

Full text available

5
2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Material Type:
Article
Add to My Research

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2018-12, Vol.72 (24), p.3200-3223 [Peer Reviewed Journal]

Copyright Elsevier Limited Dec 18, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2018.09.020 ;PMID: 30497881

Full text available

6
2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways
Material Type:
Article
Add to My Research

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology, 2017-10, Vol.70 (14), p.1785-1822 [Peer Reviewed Journal]

Copyright © 2017. Published by Elsevier Inc. ;Copyright Elsevier Limited Oct 3, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.07.745 ;PMID: 28886926

Full text available

7
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2018-10, Vol.392 (10157), p.1519-1529 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32261-X ;PMID: 30291013

Full text available

8
Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial
Material Type:
Article
Add to My Research

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2021-01, Vol.325 (1), p.39 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2020.23649 ;PMID: 33275134

Digital Resources/Online E-Resources

9
Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial
Material Type:
Article
Add to My Research

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

JAMA : the journal of the American Medical Association, 2003-07, Vol.290 (4), p.486 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.290.4.486 ;PMID: 12876091

Digital Resources/Online E-Resources

10
GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review
Material Type:
Article
Add to My Research

GIP as a Potential Therapeutic Target for Atherosclerotic Cardiovascular Disease-A Systematic Review

International journal of molecular sciences, 2020-02, Vol.21 (4), p.1509 [Peer Reviewed Journal]

2020. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms21041509 ;PMID: 32098413

Full text available

11
Aspirin Dosing in Cardiovascular Disease
Material Type:
Article
Add to My Research

Aspirin Dosing in Cardiovascular Disease

The New England journal of medicine, 2021-08, Vol.385 (8), p.764-765 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMc2110476

Full text available

12
The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review
Material Type:
Article
Add to My Research

The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review

International journal of molecular sciences, 2019-02, Vol.20 (4), p.904 [Peer Reviewed Journal]

2019. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 by the authors. 2019 ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms20040904 ;PMID: 30791450

Full text available

13
The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial
Material Type:
Article
Add to My Research

The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial

PloS one, 2014-06, Vol.9 (6), p.e100084-e100084 [Peer Reviewed Journal]

COPYRIGHT 2014 Public Library of Science ;COPYRIGHT 2014 Public Library of Science ;2014 Casas et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;cc-by (c) Casas, R. et al., 2014 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/3.0/es ;2014 Casas et al 2014 Casas et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0100084 ;PMID: 24925270

Full text available

14
Standards and core components for cardiovascular disease prevention and rehabilitation
Material Type:
Article
Add to My Research

Standards and core components for cardiovascular disease prevention and rehabilitation

Heart (British Cardiac Society), 2019-04, Vol.105 (7), p.510-515 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See:http://creativecommons.org/licenses/by-nc/4.0/. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 1355-6037 ;EISSN: 1468-201X ;DOI: 10.1136/heartjnl-2018-314206 ;PMID: 30700518

Full text available

15
Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
Material Type:
Article
Add to My Research

Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care

BMJ (Online), 2014-05, Vol.348 (7961), p.g3318-g3318 [Peer Reviewed Journal]

Selak et al 2014 ;Selak et al 2014. ;Copyright: 2014 © Selak et al 2014 ;ISSN: 0959-8138 ;ISSN: 1756-1833 ;ISSN: 0959-8146 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.g3318 ;PMID: 24868083 ;CODEN: BMJOAE

Full text available

16
Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?
Material Type:
Article
Add to My Research

Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived?

Diabetes care, 2017-07, Vol.40 (7), p.813-820 [Peer Reviewed Journal]

2017 by the American Diabetes Association. ;Copyright American Diabetes Association Jul 2017 ;2017 by the American Diabetes Association. 2017 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc16-2736 ;PMID: 28637886

Full text available

17
Xanthine oxidase inhibition for cardiovascular disease prevention
Material Type:
Article
Add to My Research

Xanthine oxidase inhibition for cardiovascular disease prevention

The Lancet (British edition), 2022-10, Vol.400 (10359), p.1172-1173 [Peer Reviewed Journal]

2022 Elsevier Ltd ;2022. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(22)01778-0

Full text available

18
Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses
Material Type:
Article
Add to My Research

Dietary fibre in hypertension and cardiovascular disease management: systematic review and meta-analyses

BMC medicine, 2022-04, Vol.20 (1), p.139-139, Article 139 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02328-x ;PMID: 35449060

Full text available

19
Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers
Material Type:
Article
Add to My Research

Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers

The American journal of clinical nutrition, 2009-05, Vol.89 (5), p.1321-1327 [Peer Reviewed Journal]

2009 INIST-CNRS ;Copyright American Society for Clinical Nutrition, Inc. May 1, 2009 ;ISSN: 0002-9165 ;EISSN: 1938-3207 ;DOI: 10.3945/ajcn.2008.27004 ;PMID: 19321573 ;CODEN: AJCNAC

Full text available

20
Repurposing drugs to treat cardiovascular disease in the era of precision medicine
Material Type:
Article
Add to My Research

Repurposing drugs to treat cardiovascular disease in the era of precision medicine

Nature reviews cardiology, 2022-11, Vol.19 (11), p.751-764 [Peer Reviewed Journal]

2022. Springer Nature Limited. ;Springer Nature Limited 2022. ;Springer Nature Limited 2022 ;ISSN: 1759-5002 ;EISSN: 1759-5010 ;DOI: 10.1038/s41569-022-00717-6 ;PMID: 35606425

Full text available

Results 1 - 20 of 16,526  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1989  (30)
  2. 1989 To 1997  (91)
  3. 1998 To 2006  (714)
  4. 2007 To 2016  (3,476)
  5. After 2016  (12,222)
  6. More options open sub menu

Subject 

  1. Science & Technology  (9,134)
  2. Life Sciences & Biomedicine  (8,261)
  3. Cardiovascular Disease  (6,450)
  4. Humans  (5,902)
  5. Mortality  (3,202)
  6. Diabetes  (3,117)
  7. Female  (2,726)
  8. Male  (2,676)
  9. Heart Failure  (2,417)
  10. Drug Dosages  (2,322)
  11. Middle Aged  (2,190)
  12. Hospitals  (2,136)
  13. Medical Research  (2,070)
  14. Aged  (2,008)
  15. Risk Factors  (1,998)
  16. Heart Attacks  (1,973)
  17. Cardiovascular Diseases  (1,909)
  18. Fda Approval  (1,809)
  19. More options open sub menu

Language 

  1. English  (16,508)
  2. Japanese  (752)
  3. Norwegian  (18)
  4. German  (17)
  5. Portuguese  (12)
  6. French  (4)
  7. Spanish  (4)
  8. Russian  (2)
  9. Turkish  (2)
  10. Polish  (1)
  11. Swedish  (1)
  12. Italian  (1)
  13. Chinese  (1)
  14. Dutch  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait